# Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.

> **NCT07068490** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 100000 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Routine use of P-CAB on DAPT
- **DRUG:** Guideline Directed Medical Therapy

## Key facts

- **NCT ID:** NCT07068490
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-22
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07068490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07068490, "Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07068490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*